| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 563,7 k € | +8.6% | 519,2 k € | +13.8% | 456,4 k € | +5.3% | 433,4 k € | +0.8% | 429,9 k € | -2.6% | 441,6 k € | +8.3% | 407,6 k € | +47.2% | 277,0 k € | +18.6% | 233,4 k € | +29.2% | 180,7 k € | +14.9% | 157,3 k € | +10.6% | 142,2 k € | +9.3% | 130,1 k € | -11.1% | 146,4 k € | |
| EBITDA | 525,7 k € | +9.0% | 482,2 k € | +12.9% | 427,0 k € | +4.1% | 410,2 k € | +2.9% | 398,6 k € | -2.3% | 408,2 k € | +9.3% | 373,4 k € | +43.5% | 260,2 k € | +19.0% | 218,6 k € | +30.8% | 167,1 k € | +12.5% | 148,6 k € | +15.2% | 129,0 k € | -0.5% | 129,6 k € | -11.0% | 145,7 k € | |
| Operating profit | 355,2 k € | +19.1% | 298,3 k € | +28.5% | 232,2 k € | -13.7% | 269,1 k € | +2.8% | 261,8 k € | -2.8% | 269,5 k € | +84.0% | 146,5 k € | +17.5% | 124,7 k € | +8.8% | 114,6 k € | +47.5% | 77,7 k € | -27.0% | 106,5 k € | +16.9% | 91,1 k € | +0.4% | 90,8 k € | +19.9% | 75,7 k € | |
| Profit/loss | 202,1 k € | +24.7% | 162,0 k € | +12.4% | 144,2 k € | -20.3% | 180,8 k € | +13.8% | 158,9 k € | +0.3% | 158,5 k € | +112.7% | 74,5 k € | +25.0% | 59,6 k € | +3.2% | 57,7 k € | +58.9% | 36,3 k € | -13.8% | 42,2 k € | -0.9% | 42,5 k € | -6.6% | 45,5 k € | +61.5% | 28,2 k € | |
| Equity | 1,3 M € | +3.5% | 1,2 M € | +2.6% | 1,2 M € | +8.0% | 1,1 M € | +19.4% | 933,9 k € | +16.0% | 805,1 k € | +13.9% | 706,6 k € | +11.8% | 632,1 k € | +10.4% | 572,5 k € | +11.2% | 514,7 k € | +99.2% | 258,4 k € | +19.5% | 216,3 k € | +24.5% | 173,7 k € | +35.5% | 128,2 k € | |
| Total assets | 3,7 M € | -4.3% | 3,9 M € | +1.5% | 3,8 M € | +25.1% | 3,0 M € | +2.1% | 3,0 M € | -1.1% | 3,0 M € | +0.9% | 3,0 M € | +17.0% | 2,5 M € | +16.6% | 2,2 M € | +30.5% | 1,7 M € | +7.6% | 1,6 M € | +59.3% | 976,7 k € | +2.3% | 955,2 k € | +0.8% | 947,8 k € | |
| Cash | 276,1 k € | -12.4% | 315,3 k € | +62.0% | 194,6 k € | +142.1% | 80,4 k € | -70.2% | 270,0 k € | +7.6% | 251,0 k € | +152.5% | 99,4 k € | -5.4% | 105,0 k € | -53.7% | 226,6 k € | +5.6% | 214,6 k € | +18.7% | 180,8 k € | +2.3% | 176,8 k € | +9.6% | 161,3 k € | +38.8% | 116,2 k € | |
| Debts | 2,4 M € | -5.9% | 2,6 M € | -1.2% | 2,6 M € | +35.1% | 1,9 M € | -5.7% | 2,0 M € | -7.4% | 2,2 M € | +0.6% | 2,2 M € | +15.3% | 1,9 M € | +19.0% | 1,6 M € | +37.4% | 1,2 M € | -10.6% | 1,3 M € | +71.2% | 757,7 k € | -3.0% | 781,3 k € | -4.7% | 819,5 k € | |
Private limited company · Braine-l'Alleud · incorporated on 19/03/2011
Private limited company profitable and well capitalised. Cash position declining (-12.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SURGIMMO is a Private limited company incorporated in 2011. Its main activity is: Buying and selling of own real estate. Its registered office is in Braine-l'Alleud.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette